Skip to main content
Premium Trial:

Request an Annual Quote

But Who's Gonna Pay For It?

One of the biggest stumbling blocks facing pharmacogenomics is getting insurance companies to realize the value of genetic testing and agree to foot the bill. That challenge is at the heart of this article from the San Jose Mercury News.

The article quotes David Lawrence, former chief executive of Kaiser Foundation Health Plan and Hospitals, as saying, "This is really a sea change in medicine. ... The whole question of what gets paid for and who pays it is going to take a while to get sorted out."

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.